WiCell Research Institute Inc

WiCell stands as a recognized world leader in the field of pluripotent stem cell banking, distribution, and cell line characterization and testing services. With an extensive catalog boasting over 1,500 diverse stem cell lines—including human embryonic stem cells (hESCs), induced pluripotent stem cells (iPSCs), and cGMP-compliant cell lines—WiCell provides researchers with the essential tools needed to advance their scientific inquiries. The clinic's commitment to quality is underscored by its rigorous testing services, which adhere to Current Good Manufacturing Practices (cGMP) and ensure reliability for various stem, immune, and engineered cell types. These services include karyotype analysis, fluorescence in situ hybridization (FISH), short tandem repeat (STR) testing, and more, all conducted by a team of highly trained analysts with extensive experience in delivering accurate and timely results. In addition to its comprehensive cell line catalog and testing services, WiCell offers a range of supportive resources designed to assist researchers at every stage of their projects. The clinic acts as a dedicated lab partner, providing not only high-quality cell lines but also assistance with reagent testing, sample submission, and cloud-based data management through the WiCell Cloud platform. By fostering a collaborative environment and maintaining a steadfast commitment to quality and integrity, WiCell has built a reputation of trust within the scientific community. As it continues to expand its offerings—including the recent addition of new cardiac trait cell lines—WiCell remains at the forefront of advancing regenerative medicine and supporting the development of innovative therapies.